Tag Archives: Cannabis Products

SK3 Group’s (OTC Pink: SKTO) Medical Greens Signs Management Agreement With Medical Marijuana Logistics Company to Provide Door-to-Door Product Delivery Safely and on Time

yakedibles

LOS ANGELES, CA–(Marketwired – Jan 24, 2014) – SK3 Group, Inc’s (OTC Pink: SKTO) subsidiary Medical Greens (“the Company”) is pleased to announce that it has signed a new management agreement with a medical marijuana-focused logistics company that will be providing secure, timely, and customer-focused door-to-door delivery of medical marijuana products to dispensaries across the […]

Medical Greens (SKTO) Announces New Topical Medical Cannabis Product Line Topikoil(TM)

Medical Greens (SKTO) Announces New Topical Medical Cannabis Product Line Topikoil(TM)

LOS ANGELES, CA–(Marketwired – Jan 13, 2014) – SK3 Group, Inc.’s (OTC Pink: SKTO) subsidiary Medical Greens (“the Company”) is pleased to announce that Berkeley Bio-Organic Research Laboratories is seeking participants to test their new proprietary cannabinoid-based skin care products — Dharmanol™ Topikoil™, and T-Hydrocan™ Topikoil™. Numerous scientific studies, as well as a host of […]

Medical Marijuana Inc.’s HempMedsPX Represents High Times Cannabis Cup Highest CBD Concentrate Award Winner

6pack_blue

SAN DIEGO, Dec. 3, 2013 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased to inform shareholders and the general public that HempMedsPX(TM) — a corporate portfolio company of Medical Marijuana, Inc. and the exclusive master distributor and contracted marketing company for CannaVest Corp. and Medical Marijuana, Inc. — represented CBD Simple by PhytoSPHERE Systems — a CannaVest Corp. […]

GrowLife Retains Washington, D.C. Based Law Firm Crowell & Moring to Provide M&A, Regulatory Guidance

growlife

WOODLAND HILLS, Calif., Dec. 3, 2013 /PRNewswire/ — GrowLife, Inc. (PHOT), a diversified company operating in the legal cannabis industry which develops, markets and deploys products and services addressing the needs of legal cannabis growing and retail operations, including hydroponic growing equipment and retail support software, is pleased to announce that the Company has retained Washington […]

Endexx Lease Program Gaining Traction

m3hub

CAVE CREEK, AZ–(Marketwired – Dec 2, 2013) – Endexx Corporation (OTC Pink: EDXC) is excited to announce that the new sales team is gaining significant traction in the Washington and Colorado markets. In the early stages of rollout of the Autospense platform we are processing lease applications for 3-5 units to be delivered after the […]

GW Pharmaceuticals to Present at the Piper Jaffray 25th Annual Health Care Conference

sativex-jpeg-resized-600

London, UK, 2 December 2013: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that Justin Gover, GW’s Chief Executive Officer, is scheduled to present at the Piper Jaffray 25th Annual Health Care […]

Nuvilex Ahead of the Curve on Cannabidiol as FDA Issues Landmark Approval

Nuvilexsq

NEW YORK, NY–(Marketwired – Nov 29, 2013) –  A new FDA approval has created a buzz inside biotechs involved with medical marijuana research. When Nuvilex, Inc. (OTCQB: NVLX) announced the formation of its new medical marijuana subsidiary, Medical Marijuana Sciences, Inc., the company’s CEO, Dr. Robert Ryan, said then that its research would focus initially on cannabidiol […]

GW Pharma rises on Swiss approval for Sativex

gw-logo

LONDON (ShareCast) – GW Pharmaceuticals (NasdaqGM:GWPH – news) has received regulatory approval in Switzerland for its treatment of spasticity due to multiple sclerosis (MS). A full marketing authorization has been granted by the Swissmedic authorities for Sativex in the treatment of moderate to severe spasticity in patients who have not responded adequately to other anti-spasticity medications. GW Pharma’s European […]

Medical Marijuana Inc. Announces Third Quarter 2013 Shareholders Report — Update & Supplemental Information

canchew3

Supplemental information & updated information to PR dated 11/21/13 are bolded and underlined. Company posts significant increase in revenue; adds new products and international shipping; represents two “highest cannabidiol (CBD)” awards for hemp oil; retains celebrity spokesperson; begins philanthropic efforts for seizure-related disorder research. SAN DIEGO, Nov. 26, 2013 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (MJNA), a […]